{"DataElement":{"publicId":"7293067","version":"1","preferredName":"Drug Accumulation Index Dose-Limiting Toxicity Risk Category","preferredDefinition":"Values and text that represent dose limiting toxicities defined by the risk of drug accumulation determined by accumulation index (AI).","longName":"DRUG_AI_RISK_CAT","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7293059","version":"1","preferredName":"Drug Accumulation Index Regimen-Limiting Toxicity Risk","preferredDefinition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance._A side effect of a drug or other treatment that is serious enough to necessitate a dose modification._The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","longName":"7293057v1.0:7293066v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"7293057","version":"1","preferredName":"Drug Accumulation Index","preferredDefinition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance.","longName":"C172152","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation Index","conceptCode":"C172152","definition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58FCAAD-A67F-1D12-E053-F662850A2CA8","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7293066","version":"1","preferredName":"Regimen-Limiting Toxicity Risk","preferredDefinition":"A side effect of a drug or other treatment that is serious enough to necessitate a dose modification.:The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","longName":"C123282:C17102","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Regimen-Limiting Toxicity","conceptCode":"C123282","definition":"A side effect of a drug or other treatment that is serious enough to necessitate a dose modification.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Risk","conceptCode":"C17102","definition":"The potential future harm that may arise from some present action. It is often combined or confused with the probability of an event which is seen as undesirable.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CB2A1-683C-0B4D-E053-F662850A632D","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A58FCAAD-A68D-1D12-E053-F662850A2CA8","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeDescription":"Created for NCI-INC0484835 - 20C0023 Drug accumulation Index request 5.11.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7293061","version":"1","preferredName":"Drug Accumulation Index Category","preferredDefinition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance._A grouping of items based on some commonality or by user defined characteristics.","longName":"DRUG_AI_CAT","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":">5.0  high risk","valueDescription":"Drug Accumulation Greater than 5","ValueMeaning":{"publicId":"7293062","version":"1","preferredName":"Drug Accumulation Greater than 5","longName":"7293062","preferredDefinition":"A drug accumulation greater than 5. It is associated with high risk of toxic drug accumulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation Greater than 5","conceptCode":"C172156","definition":"A drug accumulation greater than 5. It is associated with high risk of toxic drug accumulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FF03-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A59CC352-FF1C-17D5-E053-F662850A8916","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"2.0 to 4.99  moderate risk","valueDescription":"Drug Accumulation 2.0 to 4.99","ValueMeaning":{"publicId":"7293063","version":"1","preferredName":"Drug Accumulation 2.0 to 4.99","longName":"7293063","preferredDefinition":"A drug accumulation of 2 to 4.99. It is associated with moderate risk of toxic drug accumulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation 2.0 to 4.99","conceptCode":"C172155","definition":"A drug accumulation of 2 to 4.99. It is associated with moderate risk of toxic drug accumulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FF28-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A59CC352-FF41-17D5-E053-F662850A8916","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"1.2 to 1.99  weak risk","valueDescription":"Drug Accumulation 1.2 to 1.99","ValueMeaning":{"publicId":"7293064","version":"1","preferredName":"Drug Accumulation 1.2 to 1.99","longName":"7293064","preferredDefinition":"A drug accumulation of 1.2 to 1.99. It is associated with weak risk of toxic drug accumulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation 1.2 to 1.99","conceptCode":"C172154","definition":"A drug accumulation of 1.2 to 1.99. It is associated with weak risk of toxic drug accumulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FF4D-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A59CC352-FF66-17D5-E053-F662850A8916","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"},{"value":"<1.2  none","valueDescription":"Drug Accumulation Less than 1.2","ValueMeaning":{"publicId":"7293065","version":"1","preferredName":"Drug Accumulation Less than 1.2","longName":"7293065","preferredDefinition":"A drug accumulation of less than 1.2. It is associated with no risk of toxic drug accumulation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation Less than 1.2","conceptCode":"C172153","definition":"A drug accumulation of less than 1.2. It is associated with no risk of toxic drug accumulation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FF72-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A59CC352-FF8B-17D5-E053-F662850A8916","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7293060","version":"1","preferredName":"Drug Accumulation Index Category","preferredDefinition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance.:A grouping of items based on some commonality or by user defined characteristics.","longName":"C172152:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Drug Accumulation Index","conceptCode":"C172152","definition":"An index reflecting the extent of drug accumulation in the body. It is usually expressed as the ratio of the area under a plasma concentration-time curve (AUC) during a dosage interval at steady state compared to the AUC of a dosage interval after the first dose. It is affected by rate of dose administration, bioavailability, and clearance.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FEDB-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"ONEDATA","dateModified":"2020-05-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC352-FEEC-17D5-E053-F662850A8916","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeDescription":"Created for NCI-INC0484835 - 20C0023 Drug accumulation Index request 5.11.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Drug accumulation index (AI)","type":"Preferred Question Text","description":"Drug accumulation index (AI)","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A59CC15F-7143-1658-E053-F662850A85C1","latestVersionIndicator":"Yes","beginDate":"2020-05-14","endDate":null,"createdBy":"COOPERM","dateCreated":"2020-05-14","modifiedBy":"COOPERM","dateModified":"2020-08-13","changeDescription":"Created for NCI-INC0484835 - 20C0023 Drug accumulation Index request 5.11.2020 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}